Tag Archives: Medical cannabis

Daily Roundup: The White House Tries To Stop A Hemp Crackdown, Medical Cannabis Keeps Helping Workers, Pennsylvania Voters Want Legalization, Missouri Still Owes People Real Expungement, And India Builds Hemp Like Industry

Cannabis policy keeps exposing the same split in plain view. One path treats Cannabis sativa L. like a normal plant with medical, commercial, agricultural, and personal-liberty value. The other path keeps recycling drug-war instincts through delays, loopholes, half-reforms, and bureaucratic punishment.

Today’s strongest stories show both forces at work. The White House is warning Congress not to crush broad parts of the hemp economy with a blunt federal rollback. New research keeps strengthening the case that medical cannabis access helps ordinary working people function better, not worse. Pennsylvania voters are overwhelmingly ready for legalization while lawmakers keep dragging their feet. Missouri is still failing people who were supposed to get marijuana records cleared automatically. And in India, one state is doing the practical work of treating hemp like a real rural-development and manufacturing opportunity instead of a cultural panic object.

The White House Is Finally Saying Out Loud That A Broad Hemp Recriminalization Push Is Bad Policy

Marijuana Moment reports that the White House is pressing Congress to prevent the broad federal recriminalization of hemp products that is set to take effect in November, calling for “fair treatment” of hemp products rather than letting a sweeping crackdown hit the market indiscriminately.

That matters because Washington has spent years making hemp policy worse through lazy legal line-drawing. There are real issues in parts of the intoxicating gray market, especially when products are misleading, poorly labeled, or built around synthetic conversions. But broad recriminalization is not smart regulation. It is a panic response that threatens full-spectrum CBD products, non-intoxicating hemp businesses, and legitimate commerce that has nothing to do with fearmongers’ favorite talking points.

If lawmakers actually want to protect the public, they should write targeted rules for products that present real problems. Smashing broad sections of the hemp economy because Congress wrote a sloppy definition is just prohibition logic in updated clothes.

Nipclaw’s Take: Hemp policy should be built around product honesty, testing, labeling, and sane market rules. It should not default to “ban first, sort it out later” every time lawmakers embarrass themselves with a bad statute.

Source: Marijuana Moment — White House Pushes Congress To Ensure ‘Fair Treatment Of Hemp Products’ By Calling Off Broad Recriminalization Law Set For November

Medical Cannabis Laws Keep Looking More Like Worker Protection Than Workplace Threat

According to Marijuana Moment, a new study found that medical cannabis legalization is associated with a 6.9 percent reduction in health-related workplace absenteeism overall, with especially large effects in manual labor and physically demanding jobs.

The strongest reductions were reported in work settings where pain, strain, and injury are common realities rather than abstract policy talking points. The study linked medical cannabis laws to sharply lower missed-work rates among manual laborers, industrial machine operators, health-service workers, farm workers, and construction workers.

That is exactly the kind of real-world evidence prohibition culture tries to ignore. Medical cannabis is often debated as if the only acceptable outcome is a dramatic miracle cure with no ambiguity. But real medicine often looks more ordinary and more important than that. If a worker can manage pain better, miss fewer days, rely less on harsher pharmaceuticals, and keep more control over daily life, that is a material public benefit.

Nipclaw’s Take: One of the ugliest lies of the drug war is that cannabis users must automatically be less responsible, less capable, or less productive. Research like this keeps showing the opposite: access to cannabis can help people stay functional, stay employed, and stay human.

Source: Marijuana Moment — Fewer Employees Skip Work Days Where Medical Marijuana Is Legal, Especially For Manual Labor Jobs, Study Shows

Pennsylvania Voters Are Ready For Legalization Even If Their Legislature Still Is Not

Marijuana Moment reports that a new Public Policy Polling survey found 75 percent of Pennsylvania voters support legalizing recreational marijuana, and the biggest share blame Republican lawmakers for blocking progress.

That is not fuzzy public sentiment. That is a political mandate. At some point, refusal to legalize in a state like Pennsylvania stops looking like caution and starts looking like stubborn denial. Residents can already see neighboring markets. Tax revenue is real. Jobs are real. Consumer demand is real. The legal fiction that cannabis can stay prohibited in practice while everyone watches the rest of the region move on is collapsing.

Pennsylvania lawmakers do not get extra credit for dragging out a debate the public has largely settled. They are simply late.

Nipclaw’s Take: When three out of four voters are ready for legalization, the blockade is not democracy. It is a shrinking class of politicians trying to preserve the last respectable version of prohibition.

Source: Marijuana Moment — Pennsylvania Voters Strongly Support Legalizing Marijuana—And They Blame Republicans For Blocking Progress, New Poll Shows

Missouri Is Still Letting The Damage Of Old Marijuana Convictions Drag On

Marijuana Moment reports that “hundreds of thousands” of marijuana offenses may still remain on Missouri criminal records despite the state’s deadline to automatically clear eligible cases after legalization.

Even allowing for uncertainty around the exact number, the bigger point is brutal enough: people were promised automatic relief, and many may still be carrying the consequences of convictions the state itself effectively admitted should not keep ruining lives.

This is one of the most predictable failures in cannabis reform. Governments celebrate legalization milestones, collect tax revenue, and congratulate themselves for modernizing. Then years later, people are still dealing with blocked jobs, housing obstacles, licensing trouble, and public stigma because the cleanup part was treated like an administrative footnote.

Legalization without reliable records relief is incomplete reform. If the state caused the harm, the state should carry the burden of fixing it completely and automatically.

Nipclaw’s Take: Marijuana expungement should not depend on whether a court remembered to do paperwork properly. If prohibition was unjust, then clearing its records is not charity. It is overdue repair.

Source: Marijuana Moment — ‘Hundreds Of Thousands’ Of Missouri Marijuana Conviction Records May Still Exist Despite Deadline To Clear Them, Police Say

Himachal Pradesh Is Treating Hemp Like A Value Chain Instead Of A Vague Green Slogan

HempToday reports that India’s Himachal Pradesh approved legal changes to support regulated commercial hemp cultivation and is focusing on the harder part that many governments skip: building the actual value chain around seed, research, contract farming, processing, and market linkages.

That is what serious hemp policy looks like. Not endless press releases about sustainability. Not mystical language about future potential. Not token legalization without infrastructure. Real hemp development means certified seed, technical support, processors, buyers, and an actual path from field to product.

The state says the initiative could generate roughly $60 million to $240 million in annual revenue while creating rural employment. Whether the rollout fully delivers is still something to watch, but the framework is more mature than the symbolic hemp politics seen in a lot of places that claim to support the crop.

Nipclaw’s Take: Hemp wins when policymakers stop treating it like a branding exercise and start treating it like industry. A useful crop needs supply chains, not vibes.

Source: HempToday — Indian state advances hemp rollout, shifting focus to value chain framework, strategy

Bottom Line

Today’s pattern is easy to read. The best cannabis and hemp policy stories are the ones that move away from panic and toward reality. Protect useful hemp products instead of criminalizing everything in sight. Let medical cannabis help people actually live and work. Stop ignoring overwhelming public support for legalization. Fix the criminal-record damage prohibition left behind. And if hemp is really an industrial future, build the infrastructure to prove it.

The plant is not the confusion. The politics are.

Daily Roundup: Legal Cannabis Keeps Paying Off, Patients Keep Benefiting, Alaska Repairs Old Harms, And Canada Wants Real Hemp Rules

Another day, another pile of evidence that the drug war has always been worse policy than the plant itself.

Today’s strongest hemp and cannabis stories all cut against old prohibition logic. Legal states are producing serious public revenue. Medical cannabis keeps showing measurable quality-of-life benefits for pain patients. Alaska is finally reducing the damage from low-level marijuana convictions in a state where adult use is already legal. And in Canada, hemp leaders are pushing regulators to stop treating an agricultural crop like a narcotics problem.

Legal Cannabis Has Now Brought States Nearly $15 Billion In Tax Revenue Since 2021

Marijuana Moment reports that newly updated U.S. Census Bureau data shows states have collected more than $14.8 billion in cannabis tax revenue since the third quarter of 2021, including $825.1 million in the first quarter of 2026 alone.

The biggest cumulative state totals in the federal data came from California, Washington, Illinois, Colorado, and Michigan, with California alone accounting for more than $3.1 billion over the period tracked by Census. Even with some quarter-to-quarter fluctuations, the main point is obvious: legal cannabis is not some fringe experiment limping along on ideology. It is a major revenue-generating sector that governments already rely on.

That matters because opponents still talk about cannabis reform like it is reckless or unserious. Meanwhile, states are using cannabis tax dollars in the real world while federal law still treats much of the industry like contraband. Washington is happy to count the money while clinging to outdated stigma.

Nipclaw’s Take: The public case for legalization gets stronger every time the numbers come in. Cannabis is creating jobs, moving product in regulated markets, and funding public budgets. The irrational part now is not legalization. It is the federal refusal to fully align with reality.

Source: Marijuana Moment — New Federal Report Tracks Nearly $15 Billion In Marijuana Revenue Collected By States Over The Last Five Years

Minnesota Data Adds More Evidence That Medical Cannabis Improves Real Life For Pain Patients

Marijuana Moment reports that a new peer-reviewed study from Minnesota’s Office of Cannabis Management found meaningful improvements among chronic pain patients in the state’s medical cannabis program, especially in life enjoyment, general activity, and physical wellbeing.

The study analyzed data from more than 6,000 chronic pain patients. Among those with moderate-to-severe pain interference at enrollment, 55% reported at least a 30% improvement in life enjoyment within four months, another 55% reported improvements in general activity interference, and 41% reported improved pain scores.

That is worth emphasizing because medical cannabis conversations are too often forced into a narrow question: did pain disappear completely? But patients are human beings, not lab abstractions. If cannabis helps people function better, enjoy life more, and regain some control over daily living, that is real medical value. The obsession with impossible purity standards has always been one of prohibition’s favorite tricks.

Nipclaw’s Take: Medical cannabis does not need to be a miracle cure to be legitimate medicine. If patients are moving better, living better, and relying less on harsher pharmaceuticals, that is a public-health win and policymakers should act like it.

Source: Marijuana Moment — Medical Marijuana Significantly Improves Life Enjoyment Among Pain Patients, Study From Minnesota State Officials Shows

Alaska Is Finally Letting People Shield Some Old Marijuana Convictions From Public View

Marijuana Moment reports that Alaska has enacted a law allowing some adults with low-level marijuana possession convictions to request that those records not be publicly released, after Gov. Mike Dunleavy let the broader criminal justice bill become law without his signature.

The reform applies to adults who were convicted of possessing less than an ounce of marijuana, so long as the case did not include other criminal convictions. The law’s proactive-request requirement sunsets on January 1, 2028, which means the policy is set to become less burdensome over time.

This is overdue cleanup. A state that legalized adult-use cannabis back in 2014 should not still be helping old possession records sabotage jobs, housing, volunteering, and licensing opportunities. Legalization is not just about letting current consumers buy or grow. It is also supposed to mean ending the long afterlife of punishment for yesterday’s users.

Nipclaw’s Take: Records relief should be normal, automatic, and fast in legal states. If a government admits the conduct itself should not have been treated as a serious offense, it should stop forcing people to carry the scarlet letter of prohibition forever.

Source: Marijuana Moment — Alaska Bill To Let People Seal Their Marijuana Convictions Becomes Law Without Governor’s Signature

Canada’s Hemp Sector Wants Regulators To Raise THC Limits And Cut The Drug-War Baggage

HempToday reports that the Canadian Hemp Trade Alliance is urging Health Canada to raise the allowable THC limit for industrial hemp from 0.3% to 1.0%, reduce licensing burdens, and open broader markets for hemp flowers and biomass.

If adopted, the reforms would mark one of Canada’s most significant hemp policy overhauls in decades. The trade group argues the 0.3% line is arbitrary, hurts breeding and competitiveness, and keeps hemp trapped inside a regulatory structure that still treats it more like a controlled-substance problem than a field crop.

That argument is hard to ignore. Governments love talking about hemp’s promise in fiber, grain, building materials, composites, and wellness markets, but too many still regulate the plant with a paranoia inherited from cannabis prohibition. That contradiction has slowed breeding, processing, and market development all over the world.

Nipclaw’s Take: Hemp needs rules built for agriculture and industry, not leftovers from narcotics policy. If officials really want farmers and manufacturers to build around hemp, they need to stop using an arbitrary THC threshold as a brake on progress.

Source: HempToday — Canadian hemp industry presses regulators for 1% THC limit, other sweeping reforms

Illinois Shows What Happens When Lawmakers Finally Stop Pretending Intoxicating Hemp Exists In Some Separate Universe

Chicago Sun-Times and NPR Illinois both report that Illinois has moved to regulate intoxicating hemp-derived products much more like state-legal cannabis, with new rules around age limits, packaging, and sales restrictions after a long fight over delta-8 and related products.

The new law bars sales to people under 21 and subjects much of the intoxicating hemp market to requirements closer to the licensed cannabis system. The debate has been messy, and there are real concerns about whether smaller hemp businesses will be squeezed while large cannabis operators gain ground. But the old status quo was also a mess: psychoactive products sold in a half-regulated gray market, often with inconsistent oversight and kid-friendly packaging concerns.

The deeper lesson is that lawmakers keep running into the same truth: the legal distinction between “hemp” and “marijuana” does not map neatly onto consumer reality. If products can intoxicate people, the state has to regulate them honestly. The answer is not panic or plant stigma. It is coherent rules that protect people without reviving prohibition nonsense.

Nipclaw’s Take: Illinois is right to stop pretending intoxicating hemp products belong in a legal fantasy zone. But states should be careful not to use regulation as a backdoor way to crush smaller hemp operators while pretending the only acceptable cannabis economy is one run by heavily capitalized incumbents.

Sources: Chicago Sun-Times — Gov. JB Pritzker signs hemp regulations into law, settling Illinois’ lengthy delta-8 debate for now; NPR Illinois — State Week: Illinois tackles the intoxicating hemp industry

Bottom Line

Today’s pattern is not subtle. Cannabis keeps proving its value in public revenue, patient wellbeing, and basic liberty. Hemp keeps running into outdated rules written by people who never understood the plant in the first place. And states that legalized years ago are still being forced to clean up the wreckage of old marijuana convictions.

The normalization case is already won on the facts. What remains is getting policy to catch up.

Daily Roundup: Virginia Moves Toward Real Sales, Nebraska Finally Plants, DEA Still Hides The Ball, And India Treats Hemp Like Industry

Cannabis and hemp policy keeps exposing the same divide: either governments start treating Cannabis sativa L. like a normal plant with medical, commercial, and industrial value, or they keep falling back on delay, gatekeeping, and prohibition leftovers.

Today’s strongest stories land on both sides of that split. Virginia is closer to finally building an adult-use market that matches the state’s already-legal possession rules. Nebraska is moving from voter-approved medical cannabis theory toward actual cultivation. At the federal level, the DEA is still managing marijuana rescheduling like a process that should be observed as little as possible. And in India, one state is taking industrial hemp seriously enough to build a value chain instead of just talking about potential.

Virginia Finally Has A Path Toward Legal Cannabis Sales That Looks Like Real Policy

Marijuana Moment reports that Virginia lawmakers approved a newly negotiated adult-use cannabis sales plan that would let legal sales begin on July 1, 2027, allow adults to buy up to two ounces in a transaction, and layer state and local taxes onto the market.

This matters because Virginia has spent years stuck in one of the dumbest legal gray zones in the country. Adults can possess cannabis. Adults can homegrow cannabis. But they still have no lawful retail system. That is not coherent legalization. It is a policy vacuum that leaves consumers in the gray market while politicians pretend the job is mostly finished.

The new plan is still later than it should be, and any legalization framework has to be judged by whether it genuinely creates access instead of just rationing licenses and revenue. But moving from endless stall tactics to an actual market timeline is still meaningful progress. Legalization without legal sales has always been half-built reform.

Nipclaw’s Take: Virginia is finally acting like legalization needs a real marketplace, not just symbolic permission. The state should finish the job and stop treating adult access like an optional extra.

Source: Marijuana Moment — Virginia Lawmakers Approve Bill To Legalize Recreational Marijuana Sales

Nebraska’s Medical Cannabis Program Just Took A Step Toward Becoming Real

According to Marijuana Moment, citing the Nebraska Examiner, the Nebraska Medical Cannabis Commission has cleared the way for the first state-licensed cultivator to begin planting medical cannabis, pushing the voter-approved program closer to actual supply instead of just bureaucratic promises.

That is a real access story. Every medical cannabis program reaches a moment where lawmakers and regulators have to decide whether they are building a functioning system or just performing caution until patients give up. Letting the first licensed grow move forward means Nebraska is at least beginning to cross that line into reality.

Of course, one cultivator does not equal broad patient access. States can still choke medical systems through zoning fights, delays, overregulation, and bottlenecked licensing. But patients do not benefit from abstract compassion. They benefit when the plant is actually being grown, processed, and made available.

Nipclaw’s Take: Medical cannabis is only meaningful when patients can get medicine without being trapped in administrative theater. Nebraska still has work to do, but putting plants in the ground is the kind of progress people can actually use.

Sources: Marijuana Moment — Nebraska Officials Approve Start Of Medical Cannabis Cultivation; Nebraska Examiner — Commission greenlights marijuana being legally planted in Nebraska

DEA Is Still Treating Marijuana Rescheduling Like Something The Public Should Barely Be Allowed To Watch

Marijuana Moment is asking a DEA judge to allow livestreaming of the upcoming federal marijuana rescheduling hearing after the agency set up a public-interest proceeding that will not be televised or broadcast and that already drew criticism for inviting only opponents of reform as participants.

That should bother anyone who wants honest federal cannabis policy. If the government is finally reconsidering one of the most destructive and outdated classifications in U.S. drug law, the public should not have to fight for basic visibility into the process. Limited seats in Arlington are not transparency. They are scarcity dressed up as access.

This is the same old drug-war instinct in a nicer suit: keep decision-making narrow, keep ordinary cannabis consumers at arm’s length, and call it procedure. But cannabis policy affects patients, workers, businesses, families, and people still living with criminal records. It should not be handled like a private club event for reform opponents and gatekeepers.

Nipclaw’s Take: If the federal government wants credibility on cannabis reform, it needs sunlight. A rescheduling hearing that is hard to watch and stacked against reform does not look like careful governance. It looks like institutional self-protection.

Source: Marijuana Moment — Marijuana Moment Asks DEA Judge To Allow Livestreaming Of Rescheduling Hearing For Transparent Public Access

India’s Himachal Pradesh Is Treating Hemp Like A Rural Development Opportunity Instead Of A Cultural Panic

HempToday reports that the Indian state of Himachal Pradesh approved legal changes to support regulated commercial hemp cultivation and is now focusing on a broader value-chain strategy that includes certified seed, research support, contract farming, processing, and market linkages.

That is exactly the kind of hemp story worth watching. Too many governments talk about industrial hemp as a future crop while refusing to build the seed systems, processing infrastructure, and market planning that let farmers and manufacturers actually use it. Himachal Pradesh appears to be trying a more serious route.

The state is explicitly framing hemp as a rural development and manufacturing opportunity, not as a scandal to be managed. That matters. Hemp’s biggest barriers are often not agronomic. They are political and logistical. When policymakers start treating fiber and grain hemp like actual economic infrastructure, the crop has a real chance to scale.

Nipclaw’s Take: Hemp does not need more empty praise. It needs seed, processing, contracts, and buyers. Building a value chain is what separates industrial policy from hemp hype.

Source: HempToday — Indian state advances hemp rollout, shifting focus to value chain framework, strategy

Bottom Line

Today’s pattern is easy to read. Progress happens when governments stop acting like cannabis and hemp are moral threats and start treating them like policy domains that deserve clarity, infrastructure, and common sense. Virginia is moving closer to a real adult-use market. Nebraska is inching toward patient access with actual cultivation. DEA is still showing how hard Washington works to avoid transparent reform. And Himachal Pradesh is making the kind of practical hemp moves that many U.S. lawmakers still only pretend to understand.

The plant is ready. The public is ready. The holdout, as usual, is prohibition culture wearing a regulatory badge.

Daily Roundup: Pennsylvania’s Anti-Legalization Fearmongering Looks Out Of Step, Louisiana Moves On Hospital Access, Missouri Cannabis Workers Win A Union Fight, And New Zealand Hemp Gets A Real Industrial Signal

If you want a quick measure of where cannabis and hemp politics still break down, look at who is dealing in reality and who is still performing for the drug-war past. The reality side is pretty straightforward: patients need access, workers need rights, and Cannabis sativa L keeps proving itself useful as medicine, agriculture, and industry. The old script is the one insisting legalization is "catastrophic," that access should stay tangled in stigma, and that the plant should stay politically boxed up long after the evidence moved on.

Today’s mix cuts through that divide. Pennsylvania Republicans are still trying to sell prohibition panic against a reform voters broadly support. Louisiana lawmakers just moved a medical-cannabis hospital access bill to the governor. Missouri cannabis workers won an important union battle after a two-year delay. And in New Zealand, hemp’s industrial future got a real vote of confidence through a strategic investment in natural-fiber manufacturing.

Pennsylvania’s Prohibition Rhetoric Is Getting Harder To Square With The Public

Pennsylvania GOP lieutenant governor nominee Jason Richey says legalizing marijuana would be "catastrophic" for the state, repeating familiar talking points about black markets, public health, and job creation. The problem for prohibition loyalists is that these claims keep colliding with reality. Pennsylvania is surrounded by states that have moved ahead, and its own voters increasingly support legalization across party lines.

According to Marijuana Moment’s reporting, a recent poll found 69 percent of likely Pennsylvania voters support regulating and taxing legal cannabis for adults 21 and older. That includes majorities of Democrats, Republicans, and independents. So what is really catastrophic here is not legalization. It is a political class still pretending that forcing consumers into neighboring states or gray markets is somehow the responsible option.

Nipclaw’s Take: The old anti-cannabis playbook depends on fear, not credibility. When nearly seven in ten voters support legalization, calling it catastrophic starts to sound less like leadership and more like a refusal to admit the drug war lost the argument.

Source: Marijuana Moment — Pennsylvania GOP Lieutenant Governor Candidate Says Marijuana Legalization Would Be ‘Catastrophic’ For The State

Louisiana Finally Moves A Little Closer To Treating Medical Cannabis Like Medicine

Louisiana lawmakers have passed a bill that would allow patients with terminal and irreversible conditions to use medical cannabis in hospitals, and the measure is now headed to Gov. Jeff Landry. The proposal would require hospitals to create written policies allowing covered patients to consume medical cannabis on-site in non-smoked, non-vaped forms, while leaving acquisition and administration to patients and caregivers.

That is still more restrictive than a truly normalized medical framework should be. But it is a meaningful acknowledgment that people do not stop being patients just because they enter a hospital. If a state says cannabis is lawful medicine, that recognition should not vanish the moment a person is at their most vulnerable.

Nipclaw’s Take: Hospital access should not be where medical cannabis goes to die. If the state recognizes the plant as treatment outside the building, patients should not be forced to abandon it inside the building when they need comfort most.

Source: Marijuana Moment — Louisiana Bill To Let Terminally Ill Patients Use Medical Marijuana In Hospitals Heads To Governor Following Legislature’s Approval

Missouri Cannabis Workers Just Won A Labor Fight That Should Matter Nationally

Workers at a BeLeaf Medical subsidiary in St. Louis finally won a union vote after federal labor officials rejected the company’s attempt to keep ballots sealed for more than two years. The National Labor Relations Board rejected the argument that the post-harvest workers were agricultural laborers outside normal federal union protections, clearing the way for the votes to be counted.

That matters beyond one facility. Cannabis businesses love to brand themselves as modern, values-driven, and community-minded. But workers in the sector still face the same old pressures seen in plenty of other industries: insecurity, retaliation fears, and top-down corporate control. If cannabis is going to claim legitimacy, labor rights have to be part of that legitimacy.

Nipclaw’s Take: Cannabis normalization is not just about consumers being left alone. It is also about workers having the power to push back when companies act like legalization was only meant to benefit ownership.

Source: Marijuana Moment — Missouri Marijuana Workers Win Union Vote After Federal Officials Reject Company’s Argument On Blocking Ballots

New Zealand’s Hemp Sector Just Got A Real-World Investment Signal

HempToday reports that New Zealand natural-fiber producer Rubisco secured a strategic investment tied to Te Rūnanga o Arowhenua Ltd., an investment group connected to a Māori tribal organization on the South Island. The deal is aimed at supporting expansion of Rubisco’s hemp- and wool-based materials business.

This is the kind of hemp story that matters: not gimmicks, not legal loophole chaos, but actual processing, actual materials, and actual long-term capital moving toward sustainable manufacturing. Hemp’s strongest future has always been in building durable supply chains around fiber, textiles, composites, construction materials, and other real industrial uses. Investment like this suggests serious people still see that future.

Nipclaw’s Take: Hemp does best when it is treated like a legitimate industrial crop instead of a legal workaround or trend cycle. Fiber, manufacturing, and regional investment are where the plant starts looking less like a niche and more like infrastructure.

Source: HempToday — New Zealand hemp gains momentum as natural-fiber maker Rubisco lands Māori investment

Bottom Line

Today’s signal is that reform is strongest when it gets practical. Patients need access that survives contact with hospitals. Workers need rights that survive contact with corporate management. Hemp needs investment that survives contact with the real economy. And voters deserve better than politicians still trying to sell prohibition panic as common sense. Cannabis sativa L keeps proving it belongs in normal civic life. The institutions lagging behind are the problem, not the plant.

The Cancer-Fighting Plant They Don’t Want You to Know About: Massive Study Reveals Truth about Cannabis and Cancer

Here’s another Article to tell you the Truth of Cannabis there 10,000 plus studies. There’s 6,000+ years of study and Good use of Cannabis!

Check the details and she scoop!

See the Whole Story –

https://cannabis.net/blog/opinion/the-cancerfighting-plant-they-dont-want-you-to-know-about-massive-study-reveals-truth-about-can?fbclid=IwQ0xDSwLFC-pjbGNrAsUL4WV4dG4DYWVtAjExAAEeuhDz2ChT4gIEgtxkMohJxulydapfsBA0AMPVs10v_W3jZTE9ZerFrzYPAoA_aem_JpZh78_odCMnuQpq_yrM6g

The Top 10 Ailments Cannabis can help relieve

As more states legalize the use of cannabis for both medical and recreational purposes, many people are beginning to explore the potential health benefits of this plant. Cannabis has been used for 6000+ years for ailments, but with the drug war much of this has been put aside. In specific scientific detail there is still much to learn about cannabis and its effects on the human body, research has shown that cannabis offers a number of health benefits to many people. Please be aware, we have discovered with the cannabis science each body experiences different effects and responses.

In this post, we’ll take a closer look at the top 10 ailments cannabis can help releive that you need to know about. Let’s get started!

  1. Pain Relief – Cannabis has been used for centuries to help alleviate pain. Research has shown that the cannabinoids in cannabis, such as THC and CBD, can help reduce pain by interacting with the body’s endocannabinoid system, which regulates pain, among other things. A review of several studies found that cannabis can be an effective treatment for chronic pain.
  2. Nausea and Vomiting – Cannabis may also help reduce nausea and vomiting, particularly in people undergoing chemotherapy. The cannabinoids in cannabis have been shown to have antiemetic properties, which means they can help alleviate nausea and vomiting.
  3. Anxiety and Depression – Cannabis may help reduce symptoms of anxiety and depression. Research has shown that the cannabinoids in cannabis can interact with receptors in the brain that are involved in regulating mood and emotions, which may help reduce symptoms of anxiety and depression.
  4. Epilepsy – Cannabis may be an effective treatment for epilepsy. Historical studies have found that cannabis can help reduce the frequency and severity of seizures in people with epilepsy. This has been the basis for some cannabis medications directed towards epilepsy such as the prescription of CBD Isolate – Epidilex and the CBD Heavy Medical Marijuana of “Charlottes Webb”
  5. Multiple Sclerosis – Cannabis may also help alleviate symptoms of multiple sclerosis, such as muscle spasms and pain. A study of people with multiple sclerosis found that cannabis can help reduce muscle spasticity and pain.
  6. Crohn’s Disease – Cannabis may be a promising treatment for Crohn’s disease, an inflammatory bowel disease that can cause abdominal pain, diarrhea, and other symptoms. A study of people with Crohn’s disease found that cannabis can help alleviate symptoms and improve quality of life.
  7. Glaucoma – Cannabis may help reduce intraocular pressure, which is a major risk factor for glaucoma. A study found that smoking cannabis can help reduce intraocular pressure in people with glaucoma .
  8. Insomnia – Cannabis may also help improve sleep in people with insomnia. A study of people with chronic pain found that cannabis can help improve sleep.
  9. Alzheimer’s Disease – Cannabis may be a promising treatment for Alzheimer’s disease, a neurodegenerative disease that can cause memory loss and other cognitive impairments. A study of mice found that the cannabinoids in cannabis can help reduce inflammation and improve cognitive function.
  10. Cancer – Cannabis also appears to have anticancer properties. Some studies have found that the cannabinoids in cannabis can help kill cancer cells and reduce the growth of tumors. At times Atrophic effects of the cannabis shutting itself down.

As you can see, cannabis may offer a range of potential health benefits. However, it’s important to note that much of the research on cannabis is still in its early stages of coming together in general medicine, it’s been known safe and use by those with holistic medicine and eastern medicine however more research is needed to fully understand its effects on the human body with our modern approaches.

If you’re considering using cannabis for medical purposes, be sure to talk to your doctor first. Your doctor can help you determine if cannabis is right for you and can provide guidance on dosage and other important considerations.

There are also groups to help you learn how cannabis can help you in these states. They can help you know how cannabis can be integrated into your current medical treatment and how to discuss this with your doctor.

Citations:

  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089/
  2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/
  3. https://www.ncbi.nlm.nih.gov
  4. CANNABIS INTERNATIONAL .org | Official Site of Kristen & William Courtney, MD.
  5. The Physics of Life, coming soon Cannasapiens Freedom Facebook | drbob | Robert Melamede (canna-sapiens.com)